Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV‐positive individuals
- 3 December 2013
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 92 (2) , 133-138
Abstract
Chronic HIV infection is associated with increased risk of cardiovascular disease (CVD), including in patients with virological suppression. Persistent innate immune activation may contribute to the development of CVD via activation of monocytes in these patients. We investigated whether changes in monocyte phenotype predict subclinical atherosclerosis in virologically suppressed HIV-positive individuals with low cardiovascular risk. We enroled 51 virologically suppressed HIV-positive individuals not receiving protease inhibitors or statins and 49 age-matched uninfected controls in this study. Carotid artery intima-media thickness (cIMT) was used as a surrogate marker for CVD, and traditional risk factors, including Framingham risk scores, were recorded. Markers of monocyte activation (CD14, CD16, CCR2, CX3CR1, CD38, HLA-DR and CD11b) were measured in whole-blood samples by flow cytometry. Associations were assessed using univariate and multivariate median regressions. Median cIMT was similar between HIV-positive and HIV-negative participants (P = 0.3), although HIV-positive patients had significantly higher Framingham risk score (P = 0.009) and systemic inflammation. Expression of two monocyte markers, CD11b and CX3CR1, independently predicted carotid artery thickness in HIV-positive individuals after controlling for Framingham risk score (P = 0.025 and 0.015, respectively). These markers were not predictive of carotid artery thickening in controls. Our study indicates that monocyte surface markers may serve as novel predictors of CVD in HIV-positive individuals and is consistent with an important role for monocyte activation in the progression of HIV-related cardiovascular pathology.Keywords
Funding Information
- Australian Centre for HIV and Hepatitis Research
- National Health and Medical Research Council of Australia (543137)
- Independent Research Institute Infrastructure Support Scheme
- Postdoctoral Programme of the German Academic Exchange Service
- Occupational Trainee Scholarship of the Burnet Institute
This publication has 36 references indexed in Scilit:
- Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infectionAIDS, 2013
- Markers of atherosclerosis and inflammation and mortality in patients with HIV infectionAtherosclerosis, 2011
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) StudyThe Journal of Infectious Diseases, 2010
- Association of C-Reactive Protein and HIV Infection With Acute Myocardial InfarctionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Immune and Inflammatory Mechanisms of AtherosclerosisAnnual Review of Immunology, 2009
- C-Reactive Protein and Parental History Improve Global Cardiovascular Risk PredictionCirculation, 2008
- Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patientsAIDS, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993